ATR · Aptargroup, Inc.
$135.96
-0.79 (-0.58%)
At close · Aug 6
Market Cap
$8.69B
Shares
63.58M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$3.78B
+5.4%
FY2025
Net Income
$392.79M
+4.9%
FY2025
Gross Margin
30.93%
+0.4pp
FY2020
Operating Margin
13.26%
-0.6pp
FY2025
Diluted EPS
$5.89
+6.5%
FY2025
Operating Cash Flow
$570M
-11.4%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $3.93B | $3.78B | $3.58B | $3.49B | $3.32B | $3.23B | $2.93B | $2.86B | $2.76B | $2.47B | $2.33B | $2.32B | $2.6B | $2.52B | $2.35B | $2.36B | $2.09B | $1.86B | $2.07B | |
| — | — | — | — | — | — | $906.01M | $874.39M | $795.51M | $723.46M | $687.38M | $679.85M | $695.65M | $666.15M | $606.83M | $636.85M | $568.54M | — | — | |
| — | — | — | — | — | — | 30.93% | 30.58% | 28.77% | 29.3% | 29.49% | 29.34% | 26.78% | 26.43% | 25.86% | 27.03% | 27.2% | — | — | |
| — | $105.1M | $96.1M | $92.8M | $93.5M | $99.8M | $92.5M | $82.8M | $75.3M | $68.2M | $66.2M | $67.1M | $76.2M | $71.8M | $65.4M | $67M | $51.4M | $50.2M | — | |
| $45.79M | $45.05M | $44.12M | $44.72M | $43.57M | $41.07M | $39.79M | $27.61M | $15.46M | $10.34M | $9.32M | $4.25M | $5.33M | $5.03M | $3.18M | $2.2M | $3.62M | — | — | |
| — | $287.36M | $263.78M | $248.59M | $233.71M | $234.85M | $220.3M | $194.55M | $171.75M | $153.09M | $154.8M | $138.89M | $152.22M | $149.96M | $137.02M | $134.24M | $132.96M | $133.01M | $131.15M | |
| $8.72M | $9.84M | $13M | $45M | $6.6M | $23.24M | $26.49M | $20.47M | $63.83M | $2.21M | — | — | — | $11.8M | $3.1M | -$71K | $93K | $7.56M | — | |
| $3.46B | $3.28B | $3.09B | $3.08B | $2.94B | $2.88B | $2.59B | $2.49B | $2.48B | $2.15B | $2.02B | $1.99B | $2.29B | $2.24B | $2.07B | $2.05B | $1.81B | $1.64B | $1.84B | |
| $477.42M | $501.04M | $496.5M | $404.02M | $379.27M | $347.35M | $339.5M | $371.69M | $286.27M | $323.49M | $313.69M | $324.15M | $306.42M | $284.57M | $258.91M | $287.1M | $268.01M | $198.38M | $234.17M | |
| — | 13.26% | 13.86% | 11.58% | 11.42% | 10.76% | 11.59% | 13% | 10.35% | 13.1% | 13.46% | 13.99% | 11.8% | 11.29% | 11.03% | 12.18% | 12.82% | 10.69% | 11.3% | |
| — | $788.4M | $760.28M | $652.61M | $612.98M | $582.2M | $559.8M | $566.25M | $458.02M | $476.58M | $468.49M | $463.04M | $458.63M | $434.53M | $395.94M | $421.34M | $400.97M | $331.39M | $365.32M | |
| $63.48M | $52.74M | $43.9M | $40.42M | $40.83M | $30.28M | $33.24M | $35.49M | $32.63M | $40.6M | $35.24M | $34.62M | $21.03M | $20.51M | $18.95M | $17.3M | $14.37M | $16.49M | $18.69M | |
| $13.41M | $11.68M | $12.1M | $4.37M | $2.7M | $3.67M | $958K | $4.17M | $7.06M | $5.47M | $2.64M | $5.6M | $4.8M | $3.23M | $3M | $5.72M | $3.25M | $3.33M | $13.12M | |
| -$2.88M | -$2.03M | $3.27M | $3.21M | -$4.8M | -$3.09M | -$7.68M | $1.56M | $5.55M | $6.69M | -$407K | $163K | -$1.97M | -$2.03M | -$1.13M | -$559K | -$2.52M | -$1.34M | -$2.19M | |
| $5.12M | $7.39M | $87K | $2.23M | $467K | -$692K | -$1.44M | $135K | -$229K | -$229K | -$191K | -$718K | -$1.92M | -$883K | -$457K | -$17K | $15K | $164K | $310K | |
| -$1.64M | -$483K | $1.71M | $1.41M | -$2.11M | $4.71M | $3.06M | $0 | — | — | — | — | — | — | — | — | — | — | — | |
| $454.47M | $491.38M | $469.77M | $374.83M | $334.7M | $321.66M | $301.16M | $342.07M | $266.02M | $294.83M | $280.5M | $294.57M | $286.3M | $264.38M | $241.37M | $274.94M | $254.39M | $184.06M | — | |
| $91.59M | $98.88M | $95.59M | $90.65M | $95.15M | $78.02M | $87.07M | $99.84M | $71.25M | $74.8M | $74.89M | $95.28M | $94.68M | $92.46M | $78.95M | $91.31M | $80.8M | $59.46M | $73.23M | |
| $362.52M | $392.79M | $374.54M | $284.49M | $239.29M | $244.1M | $214.04M | $242.23M | $194.77M | $220.03M | $205.6M | $199.3M | $191.62M | $171.93M | $162.42M | $183.63M | $173.48M | $124.62M | $153.5M | |
| — | 10.4% | 10.45% | 8.16% | 7.2% | 7.56% | 7.31% | 8.47% | 7.04% | 8.91% | 8.82% | 8.6% | 7.38% | 6.82% | 6.92% | 7.79% | 8.3% | 6.72% | 7.41% | |
| -$319K | — | -$363K | -$311K | $267K | -$459K | $50K | $25K | $21K | -$1000 | $14K | -$53K | -$34K | -$68K | -$192K | -$53K | $108K | -$26K | $6000 | |
| $362.52M | $392.79M | $374.54M | $284.49M | $239.29M | $244.1M | $214.04M | $242.2M | $194.75M | $220.03M | $205.59M | $199.35M | $191.66M | $171.99M | $162.61M | $183.68M | $173.48M | $124.62M | — | |
| $360.83M | $635.89M | $254.04M | $316.89M | $213.96M | $209.77M | $274.28M | $210.76M | $144.2M | $286.44M | $148.23M | $47.05M | -$28.14M | $221.06M | $162.98M | $120.24M | $111.15M | — | — | |
| USD/shares | — | $5.97 | $5.65 | $4.34 | $3.66 | $3.72 | $3.32 | $3.81 | $3.12 | $3.52 | $3.27 | $3.19 | $2.95 | $2.60 | $2.45 | $2.76 | $2.58 | $1.84 | $2.26 |
| USD/shares | — | $5.89 | $5.53G | $4.25 | $3.59 | $3.61 | $3.21 | $3.66 | $3.00 | $3.41 | $3.17 | $3.09 | $2.85 | $2.52 | $2.38 | $2.65 | $2.48 | $1.79 | $2.18 |
| shares | — | 65.74M | 66.33M | 65.62M | 65.4M | 65.66M | 64.42M | 63.57M | 62.44M | 62.44M | 62.8M | 62.59M | 65.01M | 66.09M | 66.39M | 66.55M | 67.34M | 67.64M | — |
| shares | — | 66.73M | 67.69M | 66.91M | 66.72M | 67.68M | 66.66M | 66.15M | 64.96M | 64.6M | 64.85M | 64.49M | 67.29M | 68.21M | 68.4M | 69.27M | 69.82M | 69.79M | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2008–FY2025: $1.68B in buybacks, $1.4B in dividends.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 2.87×
EV/EBIT
—
Peer median 33.11×
P/E (TTM)
24.73×
Peer median 44.94×
Peer medians compare against the 26 similar-size Medical Instruments & Supplies companies (of 48 listed).
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Pharma Segment | $1,738,470,000 | $1,644,012,000 | $1,521,837,000 | — | — | — | — | — |
| Beauty Segment | $1,338,138,000 | $1,252,904,000 | $1,297,477,000 | — | — | — | — | — |
| Closures Segment | $736,943,000 | $721,564,000 | $706,847,000 | — | — | — | — | — |
| Aptar Beauty | — | $1,252,904,000 | $1,297,477,000 | $1,246,018,000 | $1,204,312,000 | — | — | — |
| Aptar Closures | — | $721,564,000 | $706,847,000 | $748,055,000 | $768,497,000 | — | — | — |
| Aptar Pharma | — | $1,644,012,000 | $1,521,837,000 | $1,372,449,000 | $1,297,996,000 | — | — | — |
| Beauty and Home | — | — | — | $1,461,894,000 | $1,456,208,000 | $1,320,988,000 | $1,352,714,000 | $1,426,382,000 |
| Food Beverage | — | — | — | $523,643,000 | $511,112,000 | $407,435,000 | $415,967,000 | $383,727,000 |
| Pharma | — | — | — | $1,372,449,000 | $1,297,996,000 | $1,234,107,000 | $1,091,051,000 | $954,652,000 |
| Food And Beverage | — | — | — | — | — | — | $418,017,000 | $386,689,000 |
By Geography (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| United States | $1,071,430,000 | $1,037,968,000 | $949,248,000 | $972,920,000 | — | — | — | — |
| Other Europe | $788,065,000 | $748,302,000 | $727,662,000 | $665,537,000 | $170,521,000 | $152,376,000 | $149,083,000 | $146,701,000 |
| Other Foreign Countries | $648,786,000 | $619,552,000 | $586,451,000 | $555,298,000 | — | — | — | — |
| France | $513,281,000 | $499,795,000 | $541,333,000 | $487,650,000 | $906,057,000 | $854,639,000 | $895,110,000 | $862,364,000 |
| Italy | $201,895,000 | $180,101,000 | $200,817,000 | $149,725,000 | $161,676,000 | $148,636,000 | $141,867,000 | $144,044,000 |
| Spain | $195,405,000 | $171,779,000 | $175,101,000 | $149,987,000 | — | — | — | — |
| China | $194,406,000 | $155,502,000 | $146,026,000 | $177,855,000 | — | — | — | — |
| Germany | $163,913,000 | $169,891,000 | $160,812,000 | $163,277,000 | $486,928,000 | $448,405,000 | $452,409,000 | $474,369,000 |
| Asia | — | — | — | — | $204,173,000 | $165,255,000 | $164,107,000 | $175,328,000 |
| Latin America | — | — | — | — | $216,043,000 | $194,043,000 | $220,388,000 | $235,619,000 |
| North America | — | — | — | — | $1,081,823,000 | $965,986,000 | $836,768,000 | $726,336,000 |
Key facts
CIK
896622
CUSIP
038336103
13F (30d)
225 filings
225 filers
Visit website
Investor relations